Ultralife Corporation is a manufacturer of power solutions and communications systems serving government, defense, and commercial sectors. The company operates through two segments: Battery & Energy Products, which includes non-rechargeable lithium batteries (9-volt, cylindrical, thin cell), rechargeable lithium-ion and nickel metal hydride batteries, charging systems, and uninterruptible power supplies; and Communications Systems, which comprises RF amplifiers, power supplies, cable assemblies, and integrated communication systems for military and commercial applications. Ultralife supplies original equipment manufacturers, industrial distributors, and defense departments worldwide, with applications ranging from medical devices and smoke alarms to military radios, autonomous underwater vehicles, and oil and gas drilling equipment. The company maintains operations in North America, Europe, and Asia, and has consolidated its former sub-brands, including Accutronics, Electrochem, Excell Battery, and Southwest Electronic Energy, under the Ultralife master brand.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Electronic Components Homepage ultralifecorporation.com
Sector Technology IR page investor.ultralifecorporation.com
Tags
lithium batteries, rechargeable batteries, rf amplifiers, communications systems, defense electronics, medical devices, oil and gas equipment, power supplies, charging systems, mission-critical applications, Ultralife, Ultralife Thin Cell, Ultralife HiRate, LithiumPower, SMART CIRCUIT, SODIUMPOWER, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, McDowell Research, SWE DRILL-DATA, SWE SEASAFE, SWE SOUTHWEST ELECTRONIC ENERGY CORP, Excell Battery Group, Criterion Gauge, POW-R BMS, POW-R TOTE, Electrochem
Press page ultralifecorporation.com/news

Metrics

Valuation  
Market cap $ 107.651M
Market cap (USD) $ 107.651M
P/E -36.34
PEG —
P/BV 0.80
P/S 0.56
P/OCF 53.77
P/FCF -155.12
Dividend yield —
Turnover / mcap —
Returns  
ROE -4.5%
ROI -3.3%
ROIC -2.5%
Profit margin -3.1%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 37.6%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 43
Quality score -17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 191.159M 164.456M 158.644M 131.84M 98.267M 107.712M 106.795M 87.19M 85.531M 82.46M 76.427M 66.494M 78.835M 101.657M 139.386M 166.819M 172.109M 254.7M 137.596M 93.546M 70.501M — — — 24.163M 24.514M
Net profit -5.898M 6.312M 7.197M -119K -234K 5.232M 5.205M 24.93M 7.648M 3.509M 2.869M -2.116M -926K -1.598M -2.08M -6.179M -9.241M 13.663M 5.583M -27.488M -4.345M — — — -17.262M -10.242M
Free cash flow 7.118M 14.704M -623K -2.942M 1.511M 18.619M -9.251M 6.701M 5.878M 6.434M 5.641M 2.012M 6.131M 2.083M 8.6M 9.147M -3K 15.271M -504K -1.304M -8.896M — — — -14.037M -13.478M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 5.72 7.45 6.82 3.86 6.04 6.47 7.39 6.75 6.55 4.95 6.46 3.13 3.55 2.95 4.89 6.96 3.65 10 20.02 11.07 — — — — — —
Price performance 12m -0.23 0.09 0.77 -0.36 -0.07 -0.12 0.09 0.03 0.32 -0.23 1.06 -0.12 0.2 -0.4 -0.3 0.91 -0.64 -0.5 0.81 — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 13.2M 14.7M 16M 30.1M 21.1M 20.2M 27.8M 31.8M 29.4M 33.9M
↳ YoY growth +15.3% +11.2% +9.3% +88.0% -30.1% -3.9% +37.3% +14.3% -7.5% +15.6%
↳ 5y CAGR -7.9% -6.9% +2.4% +21.7% +13.0% +9.0% +13.6% +14.7% -0.5% +10.0%
Borrowings, current (USD) — — — 1.37M 1.36M 2M 2M 2M 2.75M 4.13M
Borrowings, non-current (USD) — — — 15.8M 0.00 18.9M 19.3M 23.6M 51.5M 45.5M
Lease liabilities (USD) — — 815,000 1.87M — — — 3.54M 4.14M 3.33M
Cash and deposits (USD) 10.6M 18.2M 25.6M 7.14M 10.6M 8.33M 5.63M 10.2M 6.85M 9.35M
Intangible assets (USD) 7.19M 7.09M 6.5M 9.72M 9.21M 17.4M 15.9M 15.1M 24.6M 10.9M
Right-of-use assets (USD) — — 805,000 1.87M — — — 3.59M 4.15M 3.34M
Net debt (borrowings + leases - cash) (USD) — — — 11.9M -9.2M 12.5M 15.7M 15.4M 51.5M 43.6M
Cash flow detail
Operating cash flow (USD) 7.65M 7.27M 10.9M -2.97M 21.7M 4.33M -1.26M 1.93M 16.6M 11M
Purchases of property, plant and equipment (USD) -1.22M -1.39M -4.19M -6.28M -3.1M -2.81M -1.68M -2.55M -1.93M -3.87M
Change in receivables (cash effect) (USD) -667,000 -1.3M -1.51M -10.4M 9.21M 4.42M -7.88M -3.89M 7.6M -4.35M
Change in inventories (cash effect) (USD) 1.98M -2.54M 3.19M -3.32M 1.15M -1.3M -8.75M -943,000 -109,000 -2.35M
Share buybacks (cash effect) (USD) -607,000 — -742,000 -1.96M 0.00 — — — — —
Interest paid (cash effect) (USD) -179,000 -102,000 -132,000 -576,000 -375,000 -142,000 -930,000 -1.96M -1.86M -3.69M
Income taxes paid (cash effect) (USD) -273,000 -345,000 -220,000 -266,000 -264,000 -324,000 -354,000 -769,000 -722,000 -147,000
Share-based compensation (USD) 710,000 653,000 890,000 753,000 943,000 671,000 776,000 528,000 698,000 935,000
Operating cash flow before change in receivables (USD) 8.32M 8.57M 12.4M 7.45M 12.5M -98,000 6.62M 5.82M 9.04M 15.3M
Free cash flow (OCF - PPE - intangibles) (USD) 6.43M 5.88M 6.7M -9.25M 18.6M 1.51M -2.94M -623,000 14.7M 7.12M
Income detail
Research and development expense (USD) 5.95M 4.74M 4.51M 6.81M 5.95M 6.83M 7.08M 7.53M 8.27M 10.4M
↳ 5y CAGR -7.1% -8.1% -5.1% +5.0% +1.2% +2.8% +8.4% +10.8% +4.0% +11.8%
Total comprehensive income (USD) 1.34M 9.12M 23.8M 5.46M 5.98M -105,000 -2.22M 7.29M 5.97M -5.03M
Comprehensive income to owners (USD) 1.34M 9.12M 23.8M 5.46M 5.98M -105,000 -2.22M 7.29M 5.97M -5.03M
Reported Aug 2, 2018 May 3, 2018 May 2, 2019 Feb 6, 2020 Feb 4, 2021 Mar 8, 2022 Mar 31, 2023 Nov 12, 2024 Apr 1, 2025 Mar 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Ultralife Corporation Reports Third Quarter Results Bull 7 Bear 0 Takeover offer

NEWARK, N.Y., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2026 with the following results:

  • Sales of $48.3 million compared to $43.4 million for the 2025 third quarter

  • Gross profit of $13.3 million, or 27.5% of revenue, compared to $9.6 million, or 22.2% of revenue, for the 2025 third quarter

  • Operating income of $3.2 million compared to an operating loss of $1.0 million for the 2025 third quarter

  • GAAP EPS of $0.14 compared to ($0.07) for the 2025 third quarter

  • Adjusted EBITDA of $5.6 million compared to $2.0 million for the 2025 third quarter

  • Backlog of $136.0 million compared to $117.5 million exiting the second quarter of 2026

On October 27, 2026, Ultralife announced that it has agreed to be acquired by EnerSys (NYSE: ENS) in an all-cash transaction valued at approximately $320 million, including the assumption of net debt. The transaction is expected to close in the first quarter of 2027. In light of this pending transaction, Ultralife will not hold a conference call to discuss third quarter results.

Third Quarter 2026 Financial Results

Revenue was $48.3 million, an increase of $4.9 million, or 11.3%, as compared to revenue of $43.4 million for the third quarter of 2025. Battery & Energy Products sales increased 12.9% to $45.1 million compared to $39.9 million last year. The year-over-year increase reflects 56.7% growth in government/defense sales due primarily to a large order for conformal wearable batteries, partially offset by 5.8% decrease in commercial sales primarily due to softness in the global oil & gas market. Communications Systems sales decreased by 7.1% to $3.2 million compared to $3.4 million for the same period last year. Our total backlog exiting the third quarter was $136.0 million, the highest level in the Company’s history, compared to $117.5 million exiting the second quarter of 2026 and $90.3 million exiting the third quarter of 2025.

Gross profit was $13.3 million, or 27.5% of revenue, compared to $9.6 million, or 22.2% of revenue, for the same quarter a year ago. Battery & Energy Products gross margin was 26.7%, compared to 22.1% last year, primarily due to progress in improving manufacturing efficiencies and vertical integration of our thionyl-chloride cells as well as favorable product mix. Communications Systems gross margin was 40.1% compared to 23.3% last year, primarily due to lower warranty costs and sales mix.

Operating expenses were $10.1 million, compared to $10.6 million for the third quarter of 2025, reflecting an increase in new product development costs related to continued investment in our product offering, and a decrease in one-time, non-recurring costs of $0.6 million primarily related to the closing of our Calgary facility and certain consulting costs to help expedite our gross margin improvement in the year-earlier period. Operating expenses were 20.9% of revenue compared to 24.4% of revenue for the year-earlier period.

Operating income was $3.2 million compared to an operating loss of $1.0 million last year.

Other expense was $0.4 million primarily comprised of interest expense from the financing of our Electrochem acquisition partially offset by the third quarter estimated portion of a refundable tax credit for certain qualifying battery cells and packs we manufacture under the 45X Advanced Manufacturing Production Tax Credit. This compares to $0.8 million for the year-earlier period primarily reflecting the Electrochem acquisition financing and net foreign currency gains.

Net income attributable to Ultralife Corporation was $2.4 million or $0.14 per basic and diluted share on a GAAP basis, compared to a net loss of ($1.2) million or ($0.07) per basic and diluted share for the third quarter of 2025.

Adjusted EBITDA, defined as EBITDA including non-cash, stock-based compensation expense and one-time costs not reflective of our ongoing operations, was $5.6 million for the third quarter of 2026, or 11.7% of sales, compared to $2.0 million, or 4.7% of sales, for the year-earlier period. On a trailing twelve-month basis, adjusted EBITDA was $20.7 million or 10.8% of sales.

See the “Non-GAAP Financial Measures” section of this release below for a reconciliation of adjusted EBITDA to net income attributable to Ultralife Corporation.

About Ultralife Corporation

Ultralife Corporation is a global leader in mission-critical battery, power, communications and compute solutions for the most demanding applications in government/defense, medical, oil & gas and industrial markets across the globe.

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include uncertain global economic conditions including the impact of tariffs and inflation, reductions in revenues from key customers, delays or reductions in U.S. and foreign military spending, acceptance of our new products on a global basis, and disruptions, delays or material price increases in our supply of raw materials and components due to business conditions, new or additional tariffs, global conflicts, weather or other factors not under our control. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

| |

| ULTRALIFE CORPORATION AND SUBSIDIARIES |

| CONSOLIDATED BALANCE SHEETS (Dollars in Thousands) |

| (Unaudited) |

| |

| ASSETS |

| | | | |

| | September 30, 2026 | | December 31, 2025 |

| Current Assets: | | | |

| Cash | | $8,628 | | | | $9,345 | |

| Trade Accounts Receivable, Net | | 35,790 | | | | 33,948 | |

| Inventories, Net | | 62,314 | | | | 54,008 | |

| Prepaid Expenses and Other Current Assets | | 9,914 | | | | 8,500 | |

| Total Current Assets | | 116,646 | | | | 105,801 | |

| | | | |

| Property, Plant and Equipment, Net | | 39,011 | | | | 40,397 | |

| Goodwill | | 45,403 | | | | 45,376 | |

| Other Intangible Assets, Net | | 10,121 | | | | 10,933 | |

| Deferred Income Taxes, Net | | 10,029 | | | | 10,494 | |

| Other Non-Current Assets | | 3,193 | | | | 3,911 | |

| Total Assets | | $224,403 | | | | $216,912 | |

| | | | | |

| LIABILITIES AND SHAREHOLDERS' EQUITY |

| Current Liabilities: |

| Accounts Payable | | $19,581 | | | | $17,423 | |

| Current Portion of Long-Term Debt | | 3,125 | | | | 4,125 | |

| Accrued Compensation and Related Benefits | | 2,941 | | | | 2,754 | |

| Accrued Expenses and Other Current Liabilities | | 13,673 | | | | 13,031 | |

| Total Current Liabilities | | 39,320 | | | | 37,333 | |

| Long-Term Debt, Net | | 47,393 | | | | 45,526 | |

| Deferred Income Taxes, Net | | 897 | | | | 1,000 | |

| Other Non-Current Liabilities | | 2,156 | | | | 2,919 | |

| Total Liabilities | | 89,766 | | | | 86,778 | |

| | | | |

| Shareholders' Equity: | | | |

| Common Stock | | 2,110 | | | | 2,109 | |

| Capital in Excess of Par Value | | 193,081 | | | | 192,859 | |

| Accumulated Deficit | | (35,880) | | | | (40,340) | |

| Accumulated Other Comprehensive Loss | | (3,291) | | | | (3,141) | |

| Treasury Stock | | (21,492) | | | | (21,492) | |

| Total Ultralife Equity | | 134,528 | | | | 129,995 | |

| Non-Controlling Interest | | 109 | | | | 139 | |

| Total Shareholders’ Equity | | 134,637 | | | | 130,134 | |

| | | | |

| Total Liabilities and Shareholders' Equity | | $224,403 | | | | $216,912 | |

| | | | | | | | |

| ULTRALIFE CORPORATION AND SUBSIDIARIES |

| CONSOLIDATED STATEMENTS OF INCOME |

| (In Thousands Except Per Share Amounts) |

| (Unaudited) |

| | | | | | | | |

| | Three-Month Period Ended | | Nine-Month Period Ended |

| | September 30, | | September 30, | | September 30, | | September 30, |

| | 2026 | | 2025 | | 2026 | | 2025 |

| Revenues: | | | | | | | |

| Battery & Energy Products | $45,089 | | $39,946 | | $133,433 | | $132,134 |

| Communications Systems | 3,182 | | 3,425 | | 10,226 | | 10,544 |

| Total Revenues | 48,271 | | 43,371 | | 143,659 | | 142,678 |

| | | | | | | | |

| Cost of Products Sold: | | | | | | | |

| Battery & Energy Products | 33,071 | | 31,126 | | 99,554 | | 101,039 |

| Communications Systems | 1,907 | | 2,626 | | 6,836 | | 7,674 |

| Total Cost of Products Sold | 34,978 | | 33,752 | | 106,390 | | 108,713 |

| | | | | | | | |

| Gross Profit | 13,293 | | 9,619 | | 37,269 | | 33,965 |

| | | | | | | | |

| Operating Expenses: | | | | | | | |

| Research and Development | 3,189 | | 2,855 | | 9,375 | | 7,577 |

| Selling, General and Administrative | 6,918 | | 7,715 | | 21,486 | | 21,684 |

| Total Operating Expenses | 10,107 | | 10,570 | | 30,861 | | 29,261 |

| | | | | | | | |

| Operating Income (Loss) | 3,186 | | (951) | | 6,408 | | 4,704 |

| | | | | | | | |

| Other Expense | 441 | | 800 | | 1,340 | | 2,896 |

| Income (Loss) Before Income Taxes | 2,745 | | (1,751) | | 5,068 | | 1,808 |

| | | | | | | | |

| Income Tax Provision (Benefit) | 362 | | (504) | | 638 | | 306 |

| | | | | | | | |

| Net Income (Loss) | 2,383 | | (1,247) | | 4,430 | | 1,502 |

| | | | | | | | |

| Net Income (Loss) Attributable to Non-Controlling Interest | 15 | | (27) | | (30) | | (22) |

| | | | | | | | |

| Net Income (Loss) Attributable to Ultralife Corporation | $2,368 | | ($1,220) | | $4,460 | | $1,524 |

| | | | | | | | |

| | | | | | | | |

| Net Income (Loss) Per Share Attributable to Ultralife Common Shareholders – Basic | $.14 | | ($.07) | | $.27 | | $.09 |

| | | | | | | | |

| Net Income (Loss) Per Share Attributable to Ultralife Common Shareholders – Diluted | $.14 | | ($.07) | | $.27 | | $.09 |

| | | | | | | | |

| Weighted Average Shares Outstanding – Basic | 16,664 | | 16,646 | | 16,660 | | 16,638 |

| | | | | | | | |

| Weighted Average Shares Outstanding – Diluted | 16,697 | | 16,646 | | 16,703 | | 16,699 |

| | | | | | | | |

Non-GAAP Financial Measures

Adjusted EBITDA

In evaluating our business, we consider and use adjusted EBITDA, a non-GAAP financial measure, as a supplemental measure of our operating performance in addition to GAAP financial measures. We define adjusted EBITDA as net income attributable to Ultralife Corporation before net interest expense, provision for income taxes, depreciation and amortization, and stock-based compensation expense, plus/minus expense/income that we do not consider reflective of our ongoing continuing operations. We reconcile adjusted EBITDA to net income attributable to Ultralife Corporation, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EBITDA as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EBITDA to net income attributable to Ultralife Corporation.

| |

| ULTRALIFE CORPORATION AND SUBSIDIARIES |

| CALCULATION OF ADJUSTED EBITDA |

| (Dollars in Thousands) |

| (Unaudited) |

| |

| | Three-Month Period Ended | | Nine-Month Period Ended |

| | **September 30,**2026 | | **September 30,**2025 | | **September 30,**2026 | | **September 30,**2025 |

| | | | | | | | |

| Net Income (Loss) Attributable to Ultralife Corporation | $2,368 | | (1,220) | | $4,460 | | $1,524 |

| Adjustments: | | | | | | | |

| Interest Expense, Net | 921 | | 992 | | 2,628 | | 3,016 | |

| Income Tax Provision (Benefit) | 362 | | (504) | | 638 | | 306 | |

| Depreciation Expense | 1,098 | | 1,008 | | 3,208 | | 2,966 | |

| Amortization Expense | 267 | | 411 | | 802 | | 1,226 | |

| Stock-Based Compensation Expense | 92 | | 236 | | 181 | | 698 |

| Other Non-Recurring Costs | 278 | | 594 | | 2,009 | | 1,112 |

| One-Time Events Impacting Production | 250 | | - | | 1,067 | | - |

| Severance and Other Costs for Plant Closure | - | | 491 | | - | | 641 |

| Non-Cash Purchase Accounting Adjustment | - | | 40 | | - | | 120 |

| Adjusted EBITDA | $5,636 | | $2,048 | | $14,993 | | $11,609 |

| | | | | | | | |

| Company Contact: | Investor Relations Contact: |

| Ultralife Corporation | Alliance Advisors IR |

| Philip A. Fain | Jody Burfening |

| (315) 210-6110 | (212) 838-3777 |

| [email protected] | [email protected] |

| | |

Shareholder Tools

[Printed Materials

Printed Materials](https://investor.ultralifecorporation.com/printed-materials) [Email Alerts

Email Alerts](https://investor.ultralifecorporation.com/email-alerts) [Downloads

Downloads](https://investor.ultralifecorporation.com/download-library) [RSS

RSS](https://investor.ultralifecorporation.com/rss-news-feeds)

BACK TO TOP

• Accelerates EnerSys’ growth in mission-critical defense applications particularly high growth drone and counter drone systems

• Expands advanced, differentiated battery technologies with U.S.-based manufacturing

• Increases manufacturing capacity for specialized FEOC-compliant batteries

• Supports multiple avenues for value creation, including extending EnerSys’s capabilities into new applications within core markets, accelerating growth in existing high-growth areas, and realizing significant cost synergies

READING, Pa.,—October 27, 2026—EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial, infrastructure, and defense applications, today announced that it has entered into a definitive agreement to acquire Ultralife (NASDAQ:ULBI) for $16.00 per share in cash, representing a 166% premium to Ultralife’s unaffected closing share price on October 26, 2026. The transaction represents an enterprise value of approximately $320 million. EnerSys expects to realize $15 to $20 million in annual run-rate cost synergies within the first 18 months, reflecting the unique benefits of combining Ultralife with EnerSys.

NEWARK, N.Y., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has entered into an Agreement and Plan of Merger (“merger agreement”) with EnerSys (NYSE: ENS) under which upon closing EnerSys will acquire Ultralife Corporation in an all-cash transaction valued at approximately $320 million, including the assumption of net debt.

Under the terms of the merger agreement, which has been unanimously approved by the Boards of Directors of both companies, Ultralife Corporation shareholders will receive $16.00 in cash for each share of Ultralife Corporation common stock they own. The purchase price represents a premium of 166% to Ultralife Corporation’s closing stock price on October 26, 2026.

Strategic Benefits of the Transaction:

Ultralife is highly complementary to EnerSys and a combination creates a compelling platform for continued innovation, customer support and growth. Together, we believe EnerSys and Ultralife would be well positioned to:

  • Establish a unique portfolio of integrated, mission-critical power solutions by combining complementary products, engineering capabilities and application-specific design expertise;

  • Increase scale and broaden exposure to the large and rapidly growing defense market with capabilities across mission-critical applications in munitions, soldier power, drones, counter drones, and autonomous systems accelerating focused growth;

  • Expand EnerSys’ advanced defense power technology portfolio with the addition of Ultralife’s differentiated multi-chemistry capabilities, purpose-built advanced manufacturing capacity with existing security and environmental permits, and operational expertise to scale production of EnerSys’ proprietary liquid reserve battery technology; and

  • Deepen customer relationships by creating a broader, Foreign Entity of Concern (FEOC)-compliant product portfolio for U.S. Department of War and allied country customers.

Management Commentary:

"Combining with EnerSys is an exciting next step that will allow us to unlock value and growth opportunities for both companies, while delivering substantial and certain cash value to Ultralife shareholders,” said Michael E. Manna, President and Chief Executive Officer of Ultralife Corporation. “This transaction is a testament to the hard work and dedication of our entire organization, and now offers even greater opportunities for our valued employees. We look forward to partnering with the EnerSys team with the combined scale, resources, and shared vision to accelerate innovation and better serve our global customer base."

“This acquisition is a compelling strategic fit for EnerSys and directly advances our strategy to build a broader, more differentiated defense power platform,” said Shawn O'Connell, President and Chief Executive Officer of EnerSys. “Building on the success of our recent acquisitions, Ultralife expands our portfolio of advanced, reliable, high-performance power solutions. Together, we will be better positioned to support the U.S. Department of War (DoW) and allied forces with leading-edge, cost-effective technologies for the increasingly electrified battlefield of the future. We know the Ultralife business and its team well, and are confident that our shared commitment to engineering, problem solving, and customer focus will create a strong cultural fit. We look forward to combining our strengths to accelerate growth, enhance performance, and deliver greater value to our customers and shareholders.”

Transaction Details and Timing:

EnerSys intends to finance the transaction through cash on hand and, accordingly, is not subject to a financing contingency. The transaction has been unanimously approved by the Boards of Directors of both companies. Under the terms of the merger agreement, EnerSys, through a subsidiary, will commence a tender offer to acquire all of the outstanding shares of Ultralife common stock at a price of $16.00 per share in cash at closing, representing a total enterprise value of approximately $320 million. The transaction is subject to customary closing conditions, including the tender of at least a majority of the outstanding shares of Ultralife’s common stock and receipt of applicable regulatory approvals, and is expected to close in the first quarter of calendar year 2027. Upon completion of the transaction, Ultralife Corporation’s common stock will no longer be listed on any public market.

About Ultralife Corporation

Ultralife is a global leader in mission-critical battery, power, communications and compute solutions for the most demanding applications in government/defense, medical, oil & gas and industrial markets across the globe.

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

About EnerSys

EnerSys is a global leader in stored energy solutions helping industrial, infrastructure and defense customers address critical power and operational needs with batteries, chargers and other power equipment. The company delivers integrated solutions that combine energy storage technologies, power electronics, software-enabled intelligence, technical expertise and comprehensive global customer support. EnerSys supports customers across communications networks, data centers, energy infrastructure, material handling, transportation, aerospace and defense — including applications where power continuity is essential. Serving customers in more than 100 countries, EnerSys helps organizations manage energy more reliably, efficiently and intelligently in complex operating environments where uptime, safety and resilience matter. For more information, visit www.enersys.com.

Additional Information and Where to Find It

The Offer has not yet commenced. This communication is for informational purposes only and is neither a recommendation, nor an offer to purchase nor a solicitation of an offer to sell securities of Ultralife or any other entity, nor is it a substitute for any tender offer materials that Parent, Merger Sub or Ultralife will file with the SEC. A solicitation and an offer to buy securities of Ultralife will be made only pursuant to an offer to purchase and related materials that Parent and Merger Sub intend to file with the SEC.

At the time the Offer is commenced, Parent and Merger Sub intend to file a Tender Offer Statement on Schedule TO with the SEC, and Ultralife will thereafter file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the Offer. THE STOCKHOLDERS AND OTHER INVESTORS OF ULTRALIFE ARE URGED TO READ THE TENDER OFFER MATERIALS (INCLUDING THE OFFER TO PURCHASE, THE RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT SHOULD BE READ CAREFULLY BEFORE ANY DECISION IS MADE WITH RESPECT TO THE OFFER.

The Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement on Schedule 14D-9, will be sent to all stockholders of Ultralife at no expense to them. The Schedule TO, the Schedule 14D-9 and other related documents will also be made available for free at the SEC’s website at www.sec.gov. Additional copies may be obtained for free by contacting either EnerSys or Ultralife, or by contacting D.F. King & Co., Inc., the information agent for the Offer, toll-free at (866) 388-7535. Copies of the documents filed with the SEC by Ultralife will be available free of charge on Ultralife’s website at investor.ultralifecorporation.com. Copies of the documents filed with the SEC by EnerSys will be available free of charge on EnerSys’s website at www.enersys.com or by contacting EnerSys at (610) 208-1991.

In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement on Schedule 14D-9, EnerSys and Ultralife each file annual, quarterly and current reports, proxy statements and other information with the SEC, which are available to the public over the internet at the SEC’s website at http://www.sec.gov.

Forward-Looking Statements

This press release contains “forward-looking statements.” These statements relate to future events and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of EnerSys and Ultralife to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases, forward-looking statements may be identified by terms such as “may,” “will,” “could,” “expects,” “plans,” “anticipates,” “believes” and similar expressions intended to identify forward-looking statements. These statements reflect Ultralife’s current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, investors should not place undue reliance on these forward-looking statements. Forward-looking statements include, without limitation, statements regarding the Offer, the Merger and the other transactions contemplated by the Merger Agreement, the timing of the Offer and related transactions, the possibility that the transaction does not close, uncertainties as to how many of Ultralife’s stockholders will tender their stock in the offer; the possibility that competing offers will be made; the possibility that various closing conditions for the transaction may not be satisfied or waived, including any governmental or regulatory approvals, the anticipated benefits of the transaction, the integration of Ultralife into EnerSys, prospective performance and opportunities, post-closing operations and the outlook for the businesses of EnerSys and Ultralife, and any assumptions underlying any of the foregoing.

The following are some of the factors that could cause actual future results to differ materially from those expressed in any forward-looking statements: (i) uncertainties as to the timing of the Offer and the Merger; (ii) the risk that the Offer or the Merger may not be completed in a timely manner or at all; (iii) uncertainties as to the percentage of Ultralife’s stockholders tendering their Shares in the Offer; (iv) the possibility that competing offers or acquisition proposals for Ultralife will be made; (v) the possibility that any or all of the conditions to consummation of the Offer or the Merger may not be satisfied or waived, including failure to receive required regulatory approvals or clearances or the imposition of conditions, limitations or restrictions on those approvals; (vi) the occurrence of any event, change or other circumstance that could give rise to termination of the Merger Agreement, including circumstances requiring Ultralife to pay the Company Termination Fee or Parent to pay the Reverse Termination Fee; (vii) the effect of the announcement or pendency of the transactions on the ability of EnerSys or Ultralife to retain and hire key personnel, maintain relationships with customers, suppliers and other business partners, or conduct their businesses; (viii) risks related to diverting management’s attention from ongoing business operations; (ix) the risk that stockholder litigation relating to the transactions may result in significant costs of defense, indemnification and liability; and (x) other factors set forth from time to time in each of EnerSys’s and Ultralife’s filings with the SEC, including its Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Any forward-looking statements set forth in this press release speak only as of the date of this press release. Ultralife does not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof, other than as required by law. Investors are cautioned not to place undue reliance on these forward-looking statements.

| Company Contact: | Investor Relations Contact: |

| Ultralife Corporation | Alliance Advisors IR |

| Philip A. Fain | Jody Burfening |

| (315) 210-6110 | (212) 838-3777 |

| [email protected] | [email protected] |

Shareholder Tools

[Printed Materials

Printed Materials](https://investor.ultralifecorporation.com/printed-materials) [Email Alerts

Email Alerts](https://investor.ultralifecorporation.com/email-alerts) [Downloads

Downloads](https://investor.ultralifecorporation.com/download-library) [RSS

RSS](https://investor.ultralifecorporation.com/rss-news-feeds)

BACK TO TOP

Prompts

Ultralife Corporation (ticker ULBI), listed in United States.

Company History

Date Change Detail
Jun 9, 2008 Renamed ULTRALIFE BATTERIES INC → ULTRALIFE CORP

ETFs Holding Ultralife Corporation

ETF Weight in ETF Shares Market value As of
DFSV 0.01% 257,971 $ 4.071M Nov 12, 2026
AVSC 0.01% 13,710 $ 214.973K Nov 16, 2026
DFAT 0.01% 145,005 $ 2.288M Nov 12, 2026
DFAS 0.01% 132,506 $ 2.091M Nov 12, 2026
DXUV 0.00% 15,554 $ 245.442K Nov 12, 2026
DCOR 0.00% 48,757 $ 769.385K Nov 12, 2026
DFAC 0.00% 70,517 $ 1.113M Nov 12, 2026
DFUS 0.00% 17,068 $ 269.333K Nov 12, 2026
DFUV 0.00% 3,309 $ 52.216K Nov 12, 2026
DFAU 0.00% 206 $ 3,250.68 Nov 12, 2026
DFSU 0.00% 8 $ 126.24 Nov 12, 2026